mRNA vaccines exemplify how basic discovery research coupled with targeted translational investments remain the engine of transformative innovations that save uncountable lives and immeasurably improve their quality. GHTC and Sabin share insights from key science and policy leaders involved in Sabin’s Influenzer Initiative on the promising potential of mRNA technology.
Jamie leads the coalition’s policy and advocacy portfolio, as well as manages its engagement with GHTC members and other stakeholders and partners in government, the private sector, and civil society. She brings to the role over 12 years of experience in business development, project management, stakeholder engagement, and strategic partnership building.
Prior to joining GHTC, Jamie served as Managing Director of Devex LIVE at Devex, a media platform for the global development community. In this capacity, she oversaw all aspects of Devex LIVE, an initiative she launched in 2015 which produced numerous high-profile events around the world, including the Devex World conference in Washington, DC. Prior to serving in this position, Jamie was Devex's Senior Director for member services, where she managed a team supporting more than 1,000 organizations and 700,000 development professionals worldwide.
Before joining Devex in 2008, Jamie spent nearly three years as a Marketing Associate and then Dedicated Advisor for the Advisory Board Company and interned in the US Department of State’s Office of South Central Europe.
Jamie holds a master's degree in conflict analysis and resolution from George Mason University and a bachelor’s degree in government from the College of William & Mary. A child of diplomats, Jamie has lived in Saudi Arabia, Egypt, France, Germany, and currently resides in the Washington, DC, area with her husband Cory. In her free time, Jamie is a Zumba instructor and an avid salsa dancer.
Blog posts written by Jamie
Total of 5 blog posts
On Saturday, heads of state and government from the world’s leading economies concluded this year’s G20 Summit in Osaka, Japan by issuing a declaration committing to advance global health.
The US government has long played an indispensable role in driving global health progress as the world’s leading funder of research and development (R&D) for new vaccines, treatments, and other tools to fight neglected diseases.
On April 28, senior leaders from government, the private sector, and the global health community came together in Berlin for a lively discuss on how the G20 can advance global health innovation to drive sustainable development and health security.
Science expands our understanding, makes the impossible possible, and helps us build the future we want for all people. Science drives the work of GHTC, so we wanted to take a step back to reflect on five ways science is transforming global health.